期刊文献+

平衡溶解度实验基本程序和技术要求 被引量:15

Basic Procedure and Technical Requirements of Equilibrium Solubility Experiments
原文传递
导出
摘要 目的介绍平衡溶解度试验的基本程序和技术要求,为科研人员对平衡溶解度试验方案的设计和实施提供参考。方法从溶解度的概念及影响因素、试验的原理和测定方法、世界卫生组织(WHO)平衡溶解度项目等方面进行阐述分析。结果溶解度受缓冲液组成、温度、振荡时间、沉降时间、相分离方式等因素的影响。结论确定药物的BCS分类首先要测定药物在生理pH条件下的平衡溶解度,平衡溶解度的测定没有公认的标准方法,通过对WHO推荐的平衡溶解度试验程序的详细阐述,帮助我国广大医药工作者更好的实施平衡溶解度试验,对规范其在BCS分类和生物等效性豁免中的应用具有一定指导和借鉴意义。 OBJECTIVE To introduce the basic procedure and technical requirements of equilibrium solubility experiments and provide reference for design and conduct of equilibrium solubility experiments scheme.METHODS The concept and influence factors of solubility,principle and determination method of solubility experiments,equilibrium solubility project of world health organization were analyzed.RESULTS The influence factors of equilibrium solubility include composition of buffers, temperature,time of oscillation,time of sedimentation,techniques for separation of solid and liquid phases etc.CONCLUSION To ascertain the BCS classification of drugs,the first step is to determine the equilibrium solubility of drugs under physiological pH conditions.To date,there is no accepted standard method for the determination of equilibrium solubility.This paper introduces the basic procedure and technical requirements of equilibrium solubility experiments recommended by WHO,which would provide instructive and practical assists to conduct of equilibrium solubility experiments and standardize its application in BCS classification and biowaiver.
作者 熊婧 张涛 许明哲 金少鸿 XIONG Jing;ZHANG Tao;XU Ming-zhe;JIN Shao-hong(National Institutes for Food and Drug Control,Beijing 102629,China;Guangxi Institute for Food and Drug Control,Nanning 530021,China)
出处 《中国药学杂志》 CAS CSCD 北大核心 2019年第16期1349-1354,共6页 Chinese Pharmaceutical Journal
基金 中国食品药品检定研究院学科带头人培养基金项目资助(2017X4) 广西特聘专家项目资助
关键词 平衡溶解度 摇瓶法 生物药剂学分类系统 生物等效性豁免 世界卫生组织 equilibrium solubility shake flask BCS biowaiver WHO
  • 相关文献

参考文献5

二级参考文献38

  • 1陶涛,赵雁,陈庆华.石杉碱甲的解离常数、表观溶解度和表观油/水分配系数的测定[J].中国医药工业杂志,2005,36(8):487-489. 被引量:15
  • 2张婷婷,徐文,胡生亮,何仲贵.水飞蓟宾在不同介质中平衡溶解度和表观油水分配系数的测定[J].中国药学杂志,2006,41(20):1569-1571. 被引量:48
  • 3AMIDON GL, LENNEMAS H, SHAH VP, et al. A theoreticalbasis for a biopharmaceutic drug classification: the correlation ofin vitro drug product dissolution and in vivo bioavailability [ J ].Pharm Res, 1995, 12(3):413 -420.
  • 4FDA. Guidance for industry: “ immediate release solid oral dosageforms scale-up and postapproval changes : chemistry,manufactur-ing ,and controls, in vitro dissolution testing, and in vivo bio-equivalence documentation” [ EB/OL ]. (1995 -11 - 01 ) . http : //www. fda. gov/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/default, htm.
  • 5FDA. Guidance for industry: “ Waiver of in invo bio-equivalencestudies for immediate release solid oral dosage forms containing cer-tain active moieties/active ingredients based on a BiopharmaceuticsClassification System” [ EB/OL ]. ( 2000 - 08 - 01 ). http://www. fda. gov/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/default, htm.
  • 6WHO. Technical Report Series No. 937 ; Annex 7 : Multisource(generic) pharmaceutical products : guidelineson registration re-quirements to establish interchangeability ; Annex 8 : Proposal towaive in vivo bioequivalence requirements for WHO Model List ofEssential Medicines immediate-release, solid oral dosage forms[S].2006.
  • 7EMA. Note for guidance on the investigation of bioavailability andbioequivalence CPMP/EWP/QWP/1401/98 Revl , Appendix HI[SJ.2010.
  • 8YU LX,et al. Biopharmaceutics classification system : the scientific basis forbiowaiver extensions [ J] . Pharm Res,2002,19 ( 7 ):921 -925.
  • 9STRAUCH S, JANTRATID E,DRESSMAN JB. Comparison ofWHO and US FDA biowaiver dissolution test conditions using bio-equivalent doxycycline hyclate drug products [ J ]. J Pharm Phar-macol, 2009, 61(3) :331 -337.
  • 10AMIDON G L, LENNERN H, SHAH V P, et al. A theoretical basis for a biopharmaeeutic drug classification : the correlation of in vitro drug product dissolution and in vivo bioavailability [J]. Pharm Res, 1995, 12 (3) : 413-420.

共引文献102

同被引文献136

引证文献15

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部